Unraveling the mystery surrounding post-acute sequelae of COVID-19

RK Ramakrishnan, T Kashour, Q Hamid… - Frontiers in …, 2021 - frontiersin.org
More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …

Cerebrospinal fluid in COVID-19: a systematic review of the literature

A Lewis, J Frontera, DG Placantonakis, J Lighter… - Journal of the …, 2021 - Elsevier
Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome

KL LaRovere, BJ Riggs, TY Poussaint… - JAMA …, 2021 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) affects the nervous system in adult
patients. The spectrum of neurologic involvement in children and adolescents is unclear …

Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience

C Bryce, Z Grimes, E Pujadas, S Ahuja, MB Beasley… - Modern …, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated clinical
syndrome COVID-19 are causing overwhelming morbidity and mortality around the globe …

[HTML][HTML] High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

C Franke, C Ferse, J Kreye, SM Reincke… - Brain, behavior, and …, 2021 - Elsevier
Background COVID-19 intensive care patients can present with neurological syndromes,
usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of …

A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City

JA Frontera, S Sabadia, R Lalchan, T Fang, B Flusty… - Neurology, 2021 - AAN Enterprises
Objective To determine the prevalence and associated mortality of well-defined neurologic
diagnoses among patients with coronavirus disease 2019 (COVID-19), we prospectively …

Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms

E Song, CM Bartley, RD Chow, TT Ngo, R Jiang… - Cell Reports …, 2021 - cell.com
Individuals with coronavirus disease 2019 (COVID-19) frequently develop neurological
symptoms, but the biological underpinnings of these phenomena are unknown. Through …

Acute and post-acute neurological complications of COVID-19

A Al-Ramadan, O Rabab'h, J Shah… - Neurology international, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) is an emerging global health emergency caused by
the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …

Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic

S Dewanjee, J Vallamkondu, RS Kalra… - Molecular …, 2021 - Springer
The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …

[HTML][HTML] Mapping of SARS-CoV-2 brain invasion and histopathology in COVID-19 disease

GE Serrano, JE Walker, R Arce, MJ Glass, D Vargas… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus SARS-CoV-2 (SCV2) causes acute respiratory distress, termed
COVID-19 disease, with substantial morbidity and mortality. As SCV2 is related to previously …